Insulin Detemir is a long-acting synthetic insulin analogue that effectively controls blood glucose levels by stimulating GLP-1 secretion through enhanced glucagon gene expression and activation of Akt- and/or ERK-dependent signaling pathways. Insulin Detemir is widely employed in type 2 diabetes research to investigate molecular mechanisms of insulin signaling, glucose homeostasis, and therapeutic interventions.
CAS Nummer:
[169148-63-4]
Formel:
C267H402N64O76S6
Target-Kategorie:
Glucagon Receptor|||ERK|||Akt
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
